Intraocular Pressure Change Following Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agent

Sponsor
Prince of Songkla University
Study ID
NCT02474225
Status
Completed

Conditions

  • Intraocular Pressure

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The introduction of additional fluid into the vitreous cavity by intravitreal therapy would be expected to cause an immediate rise in the intraocular pressure. This transient, short-term intraocular pressure elevation (lasting up to 30 minutes) after intravitreal anti-vascular endothelial growth factor therapy has been well describe. The investigators aim to study the prevalence of the sustained intraocular pressure elevation associated with intravitreal injection of anti-vascular endothelial growth factor agents.

Key Dates

First listed
Jun 17, 2015
Start date
Dec 31, 2013
Status verified
Jun 2015
Primary completion
May 31, 2015
Completion
May 31, 2015

Study Design

Enrollment
70 participants (actual)

Primary Outcome Measure

Change from baseline in intraocular pressure [ Time Frame: 6-month after injection ]

Related Studies